Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Austar Lifesciences Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
2
With ROE of 1.64%, it has a Expensive valuation with a 0.75 Price to Book Value
- Over the past year, while the stock has generated a return of -6.98%, its profits have risen by 133.5% ; the PEG ratio of the company is 0.3
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -6.98% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Industrial Manufacturing)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Austar Lifesciences Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Austar Lifesciences Ltd.
-100.0%
0.08
96.91%
Hang Seng Hong Kong
8.25%
0.41
19.93%
Quality key factors
Factor
Value
Sales Growth (5y)
5.50%
EBIT Growth (5y)
1.52%
EBIT to Interest (avg)
7.29
Debt to EBITDA (avg)
0.73
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
1.75
Tax Ratio
36.40%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.51%
ROE (avg)
9.99%
Valuation Key Factors 
Factor
Value
P/E Ratio
46
Industry P/E
Price to Book Value
0.75
EV to EBIT
143.82
EV to EBITDA
12.82
EV to Capital Employed
0.80
EV to Sales
0.50
PEG Ratio
0.34
Dividend Yield
NA
ROCE (Latest)
0.55%
ROE (Latest)
1.64%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Movement
13What is working for the Company
ROCE(HY)
Highest at 4.4%
PRE-TAX PROFIT(Q)
At HKD 27.69 MM has Grown at 168.84%
RAW MATERIAL COST(Y)
Fallen by -3.57% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 18.43 %
NET PROFIT(Q)
Highest at HKD 24.32 MM
EPS(Q)
Highest at HKD 0.05
-2What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.45 times
NET SALES(Q)
Lowest at HKD 710.99 MM
Here's what is working for Austar Lifesciences Ltd.
Net Profit
At HKD 24.32 MM has Grown at 281.88%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (HKD MM)
Pre-Tax Profit
At HKD 27.69 MM has Grown at 168.84%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (HKD MM)
Net Profit
Highest at HKD 24.32 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
EPS
Highest at HKD 0.05
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Debt-Equity Ratio
Lowest at 18.43 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -3.57% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Austar Lifesciences Ltd.
Net Sales
Lowest at HKD 710.99 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Debtors Turnover Ratio
Lowest at 1.45 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






